---
title: Letermovir-inclusive combination therapy for a refractory and resistant infection
  by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant
  for MHC Class II deficiency
date: '2025-01-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39863069/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&fc=20220919201732&ff=20250126170445&v=2.18.0.post9+e462414
source: (stem cell transplantation) AND (Cytomegalovirus pneumonia)
description: Cytomegalovirus (CMV) infection remains one of the most common and challenging
  post-transplant infections. Children with inborn errors of immunity (IEI) and T-cell
  dysfunction are at high risk for CMV infection, which can be complicated by refractory
  and/or resistant cases. This case describes a Nepalese girl with MHC class II deficiency,
  who presented at 3 months of age with CMV and Pneumocystis jirovecii pneumonia.
  Hematopoietic stem cell transplantation (HSCT) was planned as a ...
disable_comments: true
---
Cytomegalovirus (CMV) infection remains one of the most common and challenging post-transplant infections. Children with inborn errors of immunity (IEI) and T-cell dysfunction are at high risk for CMV infection, which can be complicated by refractory and/or resistant cases. This case describes a Nepalese girl with MHC class II deficiency, who presented at 3 months of age with CMV and Pneumocystis jirovecii pneumonia. Hematopoietic stem cell transplantation (HSCT) was planned as a ...